BMS could soon face competition in the HCM space as Cytokinetics awaits a marketing application decision from the FDA for ...

Northeastern University researchers resurrected an extinct plant gene, turning back the evolutionary clock to pave a path forward for the development and discovery of new drugs.

Bristol Myers Squibb today announced the Phase 3 ODYSSEY-HCM trial evaluating Camzyos (mavacamten) for the treatment of adult patients with symptomatic New York Heart Association (NYHA) class II-III ...

After an earlier trial showed patients with elevated levels of a cardiac stress marker benefited from its cell therapy, the firm shifted focus to this subset.

The trial is assessing the therapy for individuals with ischemic heart failure of minimised ejection fraction.

Fire1 announced positive results from the first-in-human study of its novel, implantable heart failure (HF) management system ...

Cardiac problems associated with vascular endothelial growth factor inhibitors occur frequently in patients with cancer.

Vapourtec’s R-Series flow chemistry system, equipped with a UV-150 photochemical reactor, has been cited in research by ...

Here, we explored how NMDARs signal in tLTD. We found that, regardless of frequency, L5 PC→PC tLTD relies on the non-ionotropic preNMDAR signaling pathway mediated by JNK2, which helps to resolve the ...

Whereas obesity is a common confounder when interpreting natriuretic peptide values, and the presence of atrial fibrillation has an important influence on pretest probability, other confounders are ...

TRENTON, N.J. (PIX11) — Officials are currently investigating possible exposures to measles after an infectious individual visited New Jersey. The Department of Health advises that anyone who visited ...

The purchase includes the manufacturing process of four ELISA kits, two of which are in vitro diagnostic products for specialty diagnostics and disease monitoring.